Last reviewed · How we verify
FP9 ME-TRAP
At a glance
| Generic name | FP9 ME-TRAP |
|---|---|
| Sponsor | London School of Hygiene and Tropical Medicine |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines (PHASE1, PHASE2)
- Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FP9 ME-TRAP CI brief — competitive landscape report
- FP9 ME-TRAP updates RSS · CI watch RSS
- London School of Hygiene and Tropical Medicine portfolio CI